Home Cart Sign in  
Chemical Structure| 66990-30-5 Chemical Structure| 66990-30-5

Structure of 10,12-Tricosadiynoic acid
CAS No.: 66990-30-5

Chemical Structure| 66990-30-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

10,12-Tricosadiynoic acid is a highly specific, selective, high-affinity, orally active acyl-CoA oxidase-1 (ACOX1) inhibitor, useful for studying metabolic disorders caused by high-fat diets or obesity by improving mitochondrial lipid and ROS metabolism.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 10,12-Tricosadiynoic acid

CAS No. :66990-30-5
Formula : C23H38O2
M.W : 346.55
SMILES Code : CCCCCCCCCCC#CC#CCCCCCCCCC(O)=O
MDL No. :MFCD00041683
InChI Key :DIEDVCMBPCRJFQ-UHFFFAOYSA-N
Pubchem ID :538457

Safety of 10,12-Tricosadiynoic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Hepatocytes 100 μM 30 min Inhibit peroxisomal β-oxidation and reduce cholesterol biosynthesis J Biol Chem. 2022 Feb;298(2):101572
HEP-G2 cells 500 nM 48 h Reversed the induction of ACOX1 expression by GW4064 Front Pharmacol. 2024 Mar 26;15:1366479
HL-7702 cells 500 nM 48 h Reversed the induction of ACOX1 expression by GW4064 Front Pharmacol. 2024 Mar 26;15:1366479

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice Streptozotocin-induced diabetic mice Oral 100 mg/kg Once daily for 4 weeks Inhibit peroxisomal β-oxidation, reduce cholesterol biosynthesis and VLDL secretion J Biol Chem. 2022 Feb;298(2):101572
Mice High-fat diet-induced NAFLD model Oral gavage 224 μg/kg/day Once daily for 6 weeks Improved hepatic steatosis and reduced serum LDL levels by inhibiting the IL-1β and α-SMA pathways Front Pharmacol. 2024 Mar 26;15:1366479

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.89mL

0.58mL

0.29mL

14.43mL

2.89mL

1.44mL

28.86mL

5.77mL

2.89mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records